
    
      Primary Objective

        1. To demonstrate that the incidence of tuberculosis in patients with latent tuberculosis
           infection and treated with levofloxacin is not higher than that observed in patients
           treated with isoniazid.

           Secondary Objective

        2. To demonstrate that the efficacy of levofloxacin is not limited by adverse effects,
           paying particular attention to hepatotoxicity.
    
  